This is the first agreement of this kind, which the University of Oxford had signed with a private Chinese medicine pharmaceutical company (Shaanxi Momentum Pharmaceutical Co. Ltd., China). This research project will help Chinese medicine’s development in research that would lead to better understandings of the mechanism of its clinical efficacy in wider public and medical professions internationally, hence to make better contributions to the health care of mankind.
On the invitation of the Department of Physiology, Anatomy & Genetics, Mr Wang Bao-An, the CEO of the Company; Mr Mao Peng, the Head of R&D of the Company; Professor Zhao Zheng-Sheng, Shanxi College of Chinese Medicine and Dr Zhang Xiao-Xiao, China Society of Chinese Medicine visited the University of Oxford from 16th October to 22nd October 2014. Apart from signing the research agreement, Mr Wang and his colleagues also discussed with internationally well-known experts in the Department the details of the research project and the possibilities to form a research platform to facilitate long term collaboration between the company and the university.
Dr Yu-ling Ma, the project leader said that Professor Richard Vaughan-Jones, President of the British Physiological Society and Joint Director, Burdon Sanderson Cardiac Science Centre, will act as an academic advisor for the project; Professor Peter Robbins, Head of Department, and Dr Robert Wilkins and Professor Clive Ellory will give overall support to the project. The project has been signed for one year initially and the company is preparing a 5 year plan of research collaboration with the University of Oxford, and the university is very much interested in long term collaboration with the company.